drugset / Trial / NCT03149887

Liposomal Bupivacaine After Arthroscopic Rotator Cuff Repair

NCT03149887 ↗

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

Liposomal bupivacaine, a long-acting form of bupivacaine, has been found to be effective for postoperative pain control after total knee, total hip and total shoulder arthroplasty. We are conducting a randomized, controlled trial to evaluate pain control after arthroscopic rotator cuff repair in ambulatory patients, comparing standard care in the control group, with standard care plus the addition of injection of liposomal bupivacaine in the experimental group.

Timeline

Start
2017-12-05
Primary completion
2019-02-26
Completion
2019-03-01

Outcome

Missed primary endpoint

registry analysis (superiority test); Experimental (Liposomal Bupivacaine) vs Control (Normal Saline); p = 0.66; t-test, 2 sided NCT03149887 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 266 mg Other

Indications